These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3063506)

  • 1. Multicentre study of the efficacy and tolerance of acebutolol versus atenolol in the long term treatment of mild arterial hypertension.
    De Backer G
    Drugs; 1988; 36 Suppl 2():51-6. PubMed ID: 3063506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Once-daily acebutolol and atenolol in essential hypertension: double-blind crossover comparison.
    Turner AS; Brocklehurst JC; Napier RN
    Am Heart J; 1985 May; 109(5 Pt 2):1178-83. PubMed ID: 3993534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum lipoproteins during antihypertensive therapy with beta blockers and diuretics: a controlled long-term comparative trial.
    Middeke M; Weisweiler P; Schwandt P; Holzgreve H
    Clin Cardiol; 1987 Feb; 10(2):94-8. PubMed ID: 3545579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind comparison of the effects of long-term treatment with doxazosin or atenolol on serum lipoproteins.
    Lehtonen A; Himanen P; Saraste M; Niittymäki K; Marniemi J
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):77S-81S. PubMed ID: 2939871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A long-term study of atenolol and doxazosin in mild and moderate hypertension.
    Talseth T; Westlie L; Daae L
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():39-44. PubMed ID: 2148194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein lipids and apoproteins during beta-blocker administration: comparison of penbutolol and atenolol.
    Välimäki M; Maass L; Harno K; Nikkilä EA
    Eur J Clin Pharmacol; 1986; 30(1):17-20. PubMed ID: 3709628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of acebutolol on plasma lipids, blood glucose and serum insulin levels.
    Lehtonen A
    Acta Med Scand; 1984; 216(1):57-60. PubMed ID: 6385635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of beta blockers on blood lipid profile.
    Lehtonen A
    Am Heart J; 1985 May; 109(5 Pt 2):1192-6. PubMed ID: 2859784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacy of a single daily dose of 400 mg acebutolol and 100 mg atenolol in the treatment of arterial hypertension.
    Turner AS; Brocklehurst JC
    Curr Med Res Opin; 1983; 8(8):570-6. PubMed ID: 6653134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of clonidine hydrochloride versus atenolol monotherapy on serum lipids, lipid subfractions, and apolipoproteins in mild hypertension.
    Houston MC; Burger C; Hays JT; Nadeau J; Swift L; Bradley CA; Olafsson L
    Am Heart J; 1990 Jul; 120(1):172-9. PubMed ID: 2193493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acebutolol on the serum lipid profile.
    Clucas A; Miller N
    Drugs; 1988; 36 Suppl 2():41-50. PubMed ID: 3063505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.
    Olsen MH; Wachtell K; Beevers G; Dahlöf B; de Simone G; Devereux RB; de Faire U; Fyhrquist F; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Lyle PA; Nieminen MS; Omvik P; Oparil S; Wedel H
    J Hypertens; 2009 Mar; 27(3):567-74. PubMed ID: 19262226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of antihypertensive therapy with acebutolol on plasma lipids].
    Román O; Gac JG; Basso B; Pino ME; Pereda T; Valenzuela MA
    Rev Med Chil; 1987 Sep; 115(9):836-41. PubMed ID: 3506276
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of the hypotensive and metabolic effects of 50 and 100 mg atenolol per day.
    Lithell H; Aberg H; Selinus I
    Drugs Exp Clin Res; 1986; 12(5):393-6. PubMed ID: 3720523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of medium-term treatment of acebutolol on lipid profile].
    Bossini A; Di Veroli C
    Riv Eur Sci Med Farmacol; 1990 Apr; 12(2):91-8. PubMed ID: 2080313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised two way crossover comparison of the effects of six weeks propranolol and acebutolol therapy on plasma lipid profiles in patients with hypertension or ischaemic heart disease.
    Tyagi S; Bhargava M; Bhattacharya J; Khalilullah M
    Indian Heart J; 1990; 42(2):117-9. PubMed ID: 2081608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma lipids during chronic antihypertensive therapy with different beta-blockers.
    Fogari R; Zoppi A; Pasotti C; Poletti L; Tettamanti F; Malamani G; Corradi L
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S28-32. PubMed ID: 2481787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acebutolol effects on lipid profile.
    Schnaper HW
    Am J Cardiol; 1990 Sep; 66(9):49C-54C. PubMed ID: 2220651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of atenolol on plasma HDL cholesterol subfractions.
    Lehtonen A; Marniemi J
    Atherosclerosis; 1984; 51(2-3):335-8. PubMed ID: 6743386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.